..Or a stunning cash offer on the way for PEL 182 (BPT? STO?). Could explain all jv partners' rises. Although that might make EBR's director's buying a bit sus?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025